EP3924328 - PROCESSES AND COMPOUNDS [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 29.03.2024 Database last updated on 19.10.2024 | |
Former | Request for examination was made Status updated on 19.11.2021 | ||
Former | The international publication has been made Status updated on 22.08.2020 | ||
Former | unknown Status updated on 21.03.2020 | Most recent event Tooltip | 05.08.2024 | New entry: Reply to examination report | Applicant(s) | For all designated states Radius Pharmaceuticals, Inc. 22 Boston Wharf Road 7th Floor Boston, MA 02210 / US | [2021/51] | Inventor(s) | 01 /
MARKEY, Michael 213 Indian Meadow Drive Northborough, MA 01532 / US | [N/P] |
Former [2021/51] | 01 /
MARKEY, Michael Northborough, MA 01532 / US | Representative(s) | Potter Clarkson Chapel Quarter Mount Street Nottingham NG1 6HQ / GB | [N/P] |
Former [2021/51] | Potter Clarkson The Belgrave Centre Talbot Street Nottingham NG1 5GG / GB | Application number, filing date | 20710682.4 | 11.02.2020 | [2021/51] | WO2020US17777 | Priority number, date | US201962804391P | 12.02.2019 Original published format: US 201962804391 P | [2021/51] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020167855 | Date: | 20.08.2020 | Language: | EN | [2020/34] | Type: | A1 Application with search report | No.: | EP3924328 | Date: | 22.12.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 20.08.2020 takes the place of the publication of the European patent application. | [2021/51] | Search report(s) | International search report - published on: | EP | 20.08.2020 | (Supplementary) European search report - dispatched on: | EP | 03.04.2024 | Classification | IPC: | C07C213/02, C07C213/08, C07C231/12, C07F5/04, C07C233/25, C07C217/84, C07C237/20 | [2021/51] | CPC: |
C07F5/025 (EP,IL,KR,US);
C07C237/20 (EP,IL,KR,US);
B01J23/44 (KR);
C07C213/02 (EP,IL);
C07C213/08 (EP,IL,KR,US);
C07C217/04 (US);
C07C217/84 (EP,IL,KR);
C07C231/12 (EP,IL,KR,US);
C07C233/25 (EP,IL,US);
| C-Set: |
C07C213/02, C07C217/84 (EP);
C07C213/08, C07C217/84 (EP);
C07C231/12, C07C233/25 (EP);
C07C231/12, C07C237/20 (EP) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/51] | Extension states | BA | 03.08.2021 | ME | 03.08.2021 | Validation states | KH | 03.08.2021 | MA | 03.08.2021 | MD | 03.08.2021 | TN | 03.08.2021 | Title | German: | VERFAHREN UND VERBINDUNGEN | [2021/51] | English: | PROCESSES AND COMPOUNDS | [2021/51] | French: | PROCÉDÉS ET COMPOSÉS | [2021/51] | Entry into regional phase | 03.08.2021 | National basic fee paid | 03.08.2021 | Designation fee(s) paid | 03.08.2021 | Examination fee paid | Examination procedure | 03.08.2021 | Examination requested [2021/51] | 03.08.2021 | Date on which the examining division has become responsible | 22.03.2022 | Amendment by applicant (claims and/or description) | 09.11.2023 | Observations by third parties | 03.04.2024 | Despatch of a communication from the examining division to which search results under Rule 164(2) EPC are annexed (Time limit: M04) [2024/18] | 03.04.2024 | Despatch of a communication from the examining division (Time limit: M04) | 02.08.2024 | Reply to a communication from the examining division | Fees paid | Renewal fee | 20.12.2021 | Renewal fee patent year 03 | 14.12.2022 | Renewal fee patent year 04 | 03.01.2024 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XI]EP1577288 (EISAI CO LTD [JP]) | by applicant | US7612114 | other | WO2004058682 |